Policy Statement from the American Public Health Association (APHA): As of January 2020, 33 states, the District of Columbia, Guam, Puerto Rico and the U.S. Virgin Islands had legalized medical use of cannabis/marijuana, and 11 of those jurisdictions had legalized nonmedical adult use, typically in commercial and retail marketplaces. The federal government has not challenged
Most Recent News
Substance-related poisonings and injuries in Canada have received increasing attention in recent years due to emerging public health concerns, such as the opioid overdose crisis, the introduction of synthetic cannabinoids to the illicit market and the emergence of electronic cigarettes/vaping products on the Canadian market. Furthermore, there has been a general increase in substance-related hospitalizations
Changes in Rates of Hospitalizations due to Cannabis Harms in Ontario, Canada Before the Legalization of Nonmedical Cannabis: Retrospective Population-level Study Between 2003 and 2017
There are distinct patterns of hospitalizations due to cannabis harms in different priority populations. Young women aged 15 to 24 are a key demographic that is disproportionately burdened with a rapid increase in hospitalizations due to cannabis harms. Jurisdictions considering new approaches to cannabis control policy and addiction services should consider the rising burden of
Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact
IASIC Speaker Series Presents Where Does Cannabis Go in the Body and How It May Affect Teenagers’ Brain?
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,